JPRN-UMIN000007845已完成未知
Efficacy and Safety of treatment with tocilizumab in refractory patients with Takayasu Arteritis - ACTemra Investigation for remissiON introduction in Takayasu Arteritits (ACTION-TA)
Department of Cardiovascular Medicine Graduate School of Medicine Osaka University0 个研究点目标入组 15 人开始时间: 2012年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who have a labeled contraindication or a careful administration to tocilizumab 2)Patients who are currently participating in clinical trial studies of other investigational new drugs or devices 3)Patients who are currently participating in other clinical studies 4)Patients who are pregnant, breast-feeding or have possibilities for pregnancy 5)Patients within 6 months of onset of acute myocardial infaraction or cerebrovascular disease 6)Patients who undergoes dialysis treatment 7)Patients with advanced hepatic dysfunction (AST more than 100 IU/l or ALT more than 100 IU/l) 8)Patients who are hepatitis B virus carriers 9)Patients expected to live less than 12 months due to a complicating disease 10)Patients that researchers (cardiologists) evaluated unsuitable for participating in this clinical trial
研究者
相似试验
招募中
2 期
Evaluation the Efficacy and Safety of Tocilizumab in COVID-19COVID-19 pneumonia.Confirmed diagnosis of COVID-19RA01.0IRCT20151227025726N13Shahid Beheshti University of Medical Sciences40
招募中
不适用
The efficacy and safety of tocilizumab (trade name: Actemra) in RA patients.Rhumatoid arthritisJPRN-UMIN000002843Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine20
已完成
不适用
ong-term Safety of treatment with tocilizumab in the refractory patients with Takayasu ArteritisTakayasu arteritisJPRN-UMIN000025943Osaka Unversity9
已完成
不适用
Efficacy and safety of tocilizumab mono-therapy in patients with large vessel vasculitis (LVV; giant cell arteritis or Takayasu arteritis) and polymyalgia rheumatica (PMR)Rheumatoid arthritisJPRN-UMIN000008812Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical Universitity40
已完成
不适用
Efficacy and safety of tocilizumab mono-therapy in patients with adult-onset Still's diseaseRheumatoid arthritisJPRN-UMIN000007019Department of Rheumatology & Clinical Immunology,Saitama Medical Center, Saitama Medical Universitity40